ArticleACM-BCB ... ... : the ... ACM Conference on Bioinformatics, Computational Biology and Biomedicine. ACM Conference on Bioinformatics, Computational Biology and Biomedicine2025
MADSurv: An Uncertainty-Aware Framework for Multimodal Cancer Survival Analysis.
Article in ACM-BCB ... ... : the ... ACM Conference on Bioinformatics, Computational Biology and Biomedicine. ACM Conference on Bioinformatics, Computational Biology and Biomedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Application of deep learning in prognostic prediction of non-small cell lung cancer.Frontiers in cell and developmental biology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Multimodal learning significantly improves cancer survival prediction using multiple data types for each patient, including clinical data, pathological images, and genomic data. However, existing works often assume that each data type contributes equally, neglecting potential conflicting or unreliable information between different modalities by simply concatenating features to form a fused representation. In addition, current frameworks are trained only to rank relative risk among patients and cannot quantify the actual likelihood of survival at specific time points, limiting their utility in real-world clinical settings. In this work, we propose the Modality-Aware Discrete-Time Survival (MADSurv) framework to address these gaps. First, it implements an uncertainty-aware attention mechanism in which modality-specific expert encoders learn both predictive features and their own confidence for intelligent data fusion. This approach leads to more robust and personalized predictions by dynamically focusing on the modalities that are most reliable for each individual patient. Second, in addition to a single overall risk score, MADSurv produces a sequence of survival probabilities for discrete yearly intervals. We evaluated our proposed method on five different cancer datasets. In addition to ranking patients' overall risk using the concordance index, we also assessed the accuracy of the model's survival probability estimates on each yearly milestone using the Brier score. Our experimental results demonstrate that MADSurv achieves superior and competitive performance compared to state-of-the-art methods.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.